How does RRM diagnose and treat luteal phase deficiency?
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
RRM evaluates luteal phase deficiency through detailed cycle tracking and comprehensive hormone analysis to identify and treat the root causes of inadequate progesterone production.
In RRM practice, luteal phase deficiency (LPD) represents insufficient progesterone production during the second half of the menstrual cycle, potentially contributing to infertility and early pregnancy loss. Rather than relying on isolated lab values, RRM clinicians use CrMS cycle tracking to identify patterns such as short luteal phases (less than 10 days), pre-menstrual spotting, or low post-peak temperatures that suggest inadequate corpus luteum function.
RRM Diagnostic Approach
The RRM evaluation combines cycle charting observations with properly timed hormone testing. Midluteal progesterone levels are measured at peak plus 7 days to assess corpus luteum function during optimal timing. More importantly, RRM investigates underlying causes including thyroid dysfunction, hyperprolactinemia, insulin resistance, and nutritional deficiencies that can impair ovarian function and progesterone production.
Root Cause Treatment
Once identified, RRM addresses the specific causes of luteal phase inadequacy. Thyroid optimization, prolactin normalization through dopamine agonists when indicated, and metabolic support often restore normal luteal function. Targeted progesterone supplementation may be used during the diagnostic and treatment phase, typically started after confirmed ovulation and continued through early pregnancy when conception occurs.
Cycle Monitoring and Adjustment
Women learn to track their cycles using CrMS methods, providing ongoing feedback about luteal phase quality and treatment response. This body literacy approach helps couples time conception attempts and monitor improvement in real-time. The goal is restoration of normal cycle function rather than indefinite hormone supplementation.
- ASRM 2021 acknowledges LPD as a recognized condition but notes diagnostic challenges with single measurements
- Studies show thyroid dysfunction and hyperprolactinemia commonly contribute to luteal phase inadequacy (Krassas et al. 2008)
- Progesterone supplementation after ovulation confirmation may reduce early pregnancy loss in select patients
RRM treats luteal phase deficiency by identifying and correcting underlying endocrine disruptions while teaching couples to track cycle quality and optimize conception timing.
This information is educational and not a substitute for individualized medical care. Consult your RRM clinician or healthcare provider for guidance specific to your situation.